The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Lbp Am Sa

LBP AM SA increased its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,913 shares of the medical device company's stock after acquiring an additional 3,116 shares during the period. LBP AM SA's holdings in Cooper Companies were worth $4,589,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in COO. Raymond James Financial Inc. bought a new stake in Cooper Companies in the fourth quarter worth about $64,826,000. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after acquiring an additional 574,899 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Wealthfront Advisers LLC raised its stake in shares of Cooper Companies by 4,594.1% during the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company's stock valued at $52,383,000 after acquiring an additional 557,673 shares in the last quarter. Finally, Alecta Tjanstepension Omsesidigt bought a new position in Cooper Companies in the fourth quarter worth approximately $49,550,000. Institutional investors own 24.39% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several research firms have issued reports on COO. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Citigroup cut their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, Robert W. Baird dropped their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $111.89.

Cooper Companies Price Performance

Shares of COO traded down $0.25 during mid-day trading on Tuesday, hitting $79.67. 676,176 shares of the company were exchanged, compared to its average volume of 1,259,429. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a 50 day moving average of $90.94 and a 200-day moving average of $98.75. The stock has a market cap of $15.93 billion, a price-to-earnings ratio of 40.85, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.